Lupin secures tentative FDA approval for Xywav oral solution generic
Global pharma leader, Lupin Limited, proudly announced its tentative approval from the United States Food and Drug Administration (U.S. FDA). This nod gives green light ... Read More
Lupin bags tentative FDA approval for Tolvaptan Tablets, a generic of Jynarque
Lupin Limited, a global pharmaceutical powerhouse, proudly announces that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Lupin’s Nagpur Unit-1 gets FDA nod with VAI status
Global pharmaceutical powerhouse, Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) ... Read More
Lupin acquires five legacy brands, intensifies Indian pharma dominance
In a move that has set the pharmaceutical industry abuzz, global pharma titan Lupin Limited has revealed the acquisition of five key legacy brands, zeroing ... Read More
Lupin, Mark Cuban’s Cost Plus Drugs and COPD Foundation boost COPD treatment access
In a significant healthcare development, global pharmaceutical giant Lupin Limited (Lupin) has entered into a groundbreaking collaboration with Mark Cuban Cost Plus Drug Company (Cost ... Read More
Lupin Pharma Canada debuts Propranolol LA, filling gap left by Inderal LA
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited, has officially launched its Propranolol LA capsules in Canada, signaling a milestone in affordable healthcare ... Read More
Lupin Limited gains FDA approval for generic equivalent of Esbriet Tablets
Lupin Limited announced today that it has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application ... Read More
Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim
In a strategic move to fortify its position in the pharmaceutical domain, global major Lupin Limited proclaimed its acquisition of coveted diabetes brands ONDERO and ... Read More
Lupin secures FDA nod for generic Bromday Ophthalmic Solution
Global pharmaceutical titan, Lupin Limited, has officially declared its success in securing the esteemed approval from the United States Food and Drug Administration (FDA). This ... Read More
Lupin gains FDA approval for generic Toprol-XL Tablets
Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval from the United States Food and Drug ... Read More